Walgreens Boots Alliance, Inc. Quarterly Liabilities and Equity in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Walgreens Boots Alliance, Inc. quarterly Liabilities and Equity history and growth rate from Q3 2014 to Q3 2024.
  • Walgreens Boots Alliance, Inc. Liabilities and Equity for the quarter ending August 31, 2024 was $81B, a 16.1% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $81B -$15.6B -16.1% Aug 31, 2024 10-K 2024-10-15
Q2 2024 $83B -$15.6B -15.8% May 31, 2024 10-Q 2024-06-27
Q1 2024 $84.2B -$16.3B -16.2% Feb 29, 2024 10-Q 2024-03-28
Q4 2023 $97.8B +$4.95B +5.33% Nov 30, 2023 10-Q 2024-01-04
Q3 2023 $96.6B +$6.5B +7.22% Aug 31, 2023 10-K 2024-10-15
Q2 2023 $98.6B +$5.85B +6.3% May 31, 2023 10-Q 2023-06-27
Q1 2023 $100B +$7.8B +8.41% Feb 28, 2023 10-Q 2023-03-28
Q4 2022 $92.9B -$3.63B -3.76% Nov 30, 2022 10-Q 2023-01-05
Q3 2022 $90.1B +$8.84B +10.9% Aug 31, 2022 10-K 2023-10-12
Q2 2022 $92.8B +$839M +0.91% May 31, 2022 10-Q 2022-06-30
Q1 2022 $92.7B +$1.76B +1.94% Feb 28, 2022 10-Q 2022-03-31
Q4 2021 $96.5B +$7.34B +8.23% Nov 30, 2021 10-Q 2022-01-06
Q3 2021 $81.3B -$5.89B -6.76% Aug 31, 2021 10-K 2022-10-13
Q2 2021 $91.9B +$5.48B +6.34% May 31, 2021 10-Q 2021-07-01
Q1 2021 $90.9B +$917M +1.02% Feb 28, 2021 10-Q 2021-03-31
Q4 2020 $89.2B -$1.64B -1.81% Nov 30, 2020 10-Q 2021-01-07
Q3 2020 $87.2B +$19.6B +29% Aug 31, 2020 10-K 2021-10-14
Q2 2020 $86.4B +$17.9B +26% May 31, 2020 10-Q 2020-07-09
Q1 2020 $90B +$19.6B +27.8% Feb 29, 2020 10-Q 2020-04-02
Q4 2019 $90.8B +$20.9B +29.8% Nov 30, 2019 10-Q 2020-01-08
Q3 2019 $67.6B -$526M -0.77% Aug 31, 2019 10-K 2020-10-15
Q2 2019 $68.6B -$1.57B -2.23% May 31, 2019 10-Q 2019-06-27
Q1 2019 $70.4B -$382M -0.54% Feb 28, 2019 10-Q 2019-04-02
Q4 2018 $69.9B +$3.32B +4.99% Nov 30, 2018 10-Q 2018-12-20
Q3 2018 $68.1B +$2.12B +3.2% Aug 31, 2018 10-K 2019-10-28
Q2 2018 $70.2B -$4.02B -5.42% May 31, 2018 10-Q 2018-06-28
Q1 2018 $70.8B -$1.69B -2.33% Feb 28, 2018 10-Q 2018-03-28
Q4 2017 $66.6B -$5.29B -7.36% Nov 30, 2017 10-Q 2018-01-04
Q3 2017 $66B -$6.68B -9.19% Aug 31, 2017 10-K 2018-10-11
Q2 2017 $74.2B +$6.84B +10.2% May 31, 2017 10-Q 2017-06-29
Q1 2017 $72.5B +$6.12B +9.22% Feb 28, 2017 10-Q 2017-04-05
Q4 2016 $71.9B +$3.26B +4.74% Nov 30, 2016 10-Q 2017-01-05
Q3 2016 $72.7B +$3.91B +5.68% Aug 31, 2016 10-K 2017-10-25
Q2 2016 $67.3B -$3.31B -4.69% May 31, 2016 10-Q 2016-07-06
Q1 2016 $66.4B -$4.97B -6.97% Feb 29, 2016 10-Q 2016-04-05
Q4 2015 $68.7B +$58.6B +585% Nov 30, 2015 10-Q 2016-01-07
Q3 2015 $68.8B +$31.5B +84.7% Aug 31, 2015 10-K 2016-10-20
Q2 2015 $70.6B May 31, 2015 10-Q 2015-07-09
Q1 2015 $71.4B Feb 28, 2015 10-Q 2015-04-09
Q4 2014 $10B Nov 30, 2014 10-Q 2014-12-30
Q3 2014 $37.3B Aug 31, 2014 10-K 2015-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.